Objectives To review the literature and provide an update on the mechanisms of action and
therapeutic uses of oral colchicine in arthritis and inflammatory conditions. Methods We …

Behçet's disease (BD) is a rare systemic vasculitis characterized by oral aphthous ulcers,
genital ulcers, ocular lesions and other systemic manifestations. BD occurs most frequently …

Several new treatment modalities with different mechanisms of action have been studied in
patients with Behçet's syndrome (BS). The aim of the current effort was to update the …

Behçet's disease (BD) is a chronic, relapsing, inflammatory multisystem disease of unknown
etiology. Oral ulcers, genital ulcers, cutaneous lesions, and ocular and articular involvement …

Background Colchicine is a widely used drug to treat inflammatory diseases. Due to its long
historical use in medicine, controlled clinical trials have been small and there remains some …

Colchicine is a treatment for gout that has been used for more than a millennium. It is the
treatment of choice for familial Mediterranean fever and its associated complication …

Although colchicine has been a focus of research, debate, and controversy for thousands of
years, the US Food and Drug Administration just approved it in 2009. Over the past decade …

Neutrophilic dermatoses are a heterogeneous group of inflammatory skin disorders that
present with unique clinical features but are unified by the presence of a sterile …

Background Oral ulcers, the hallmark of Behçet's syndrome, can be resistant to conventional
treatment; therefore, alternative agents are needed. Apremilast is an oral phosphodiesterase …

Behçet's disease is a systemic vasculitis characterized by attacks of acute inflammation,
which can affect almost every vascularized area of the body. There is a close correlation …